The effect of opioids on the development of postoperative intra-abdominal adhesions

Digestive Diseases and Sciences

Volumn 51, Issue 3, 2006, Pages 560-565

  Khorram Manesh, Amir ^a,b   Ardakani, Jalal Vahedian ^c   Behjati, Hamid Reza ^c   Nylund, Gunnar ^a,b   Delbro, Dick ^b,d  

^a Section of Haematology   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d LINNAEUS UNIVERSITY   (Sweden)

Author keywords

Intra abdominal adhesions; Opioid receptors; Postoperative

Indexed keywords

MORPHINE; NALOXONE; OPIATE;

ABDOMEN; ABDOMINAL DISEASE; ABDOMINAL SURGERY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DEPENDENCE; FEMALE; INTRAABDOMINAL LESION; MORPHINE ADDICTION; NONHUMAN; OPIATE ADDICTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RAT; REOPERATION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

ADHESIONS; ANIMALS; CECUM; DISEASE MODELS, ANIMAL; FEMALE; LAPAROTOMY; MORPHINE; NARCOTICS; OPIUM; POSTOPERATIVE COMPLICATIONS; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; REFERENCE VALUES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33645852861     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3170-7     Document Type: Article

References (34)

1. Menzies D, Ellis H: Intestinal obstruction from adhesions - how big is the problem? Ann R Coll Surg Engl 72:60-63, 1990
2. Ellis H: The clinical significance of adhesions: focus on intestinal obstruction. Eur J Surg Suppl 577:5-9, 1997
3. Ivarsson ML, Holmdahl L, Franzen G, Risberg B: Cost of bowel obstruction resulting from adhesions. Eur J Surg 163:679-684, 1997
4. Sulaiman H, Gabella G, Davis C, et al.: Presence and distribution of sensory nerve fibers in human peritoneal adhesions. Ann Surg 234:256-261, 2001
5. Ellis H: The magnitude of adhesion related problems. Ann Chir Gynaecol 87:9-11, 1998
6. Dijkstra FR, Nieuwenhuijzen M, Reijnen MM, van Goor H: Recent clinical developments in pathophysiology, epidemiology, diagnosis and treatment of intra-abdominal adhesions. Scand J Gastroenterol Suppl 232: 525-529, 2000
7. Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL: Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 18:260-273, 2001
8. Vasko MR: Opioid analgesic drugs. In Goth's Medical Pharmacology, 13th ed. Clark WG, Bratter DC, Johnson AR (eds). St. Louis, Mosby-Year Book, 1992, pp 318-335
9. Way WL, Fields HL, Schumacher MA: Opioid analgesics & antagonists. In Basic & Clinical Pharmacology, 8th ed. Katzung BG (ed). New York, McGraw-Hill, 2001, pp 512-531
10. Badawy AA, Evans CM, Evans M: Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water. Br J Pharmacol 75:485-491, 1982
11. Leung CM, Dai S, Ogle CW: Rapid induction of dependence to morphine in rats. Neuropharmacology 25:305-307, 1986
12. Gellert VF, Holtzman SG: Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 205:536-546, 1978
13. Swolin K: Experimentelle studien zur prophylaxe von intraabdominalen verwachsungen. Acta Obstet Gynecol Scand 45:473-498, 1966
14. Kamffer WJ, Jooste EV, Nel JT, de Wet JI: Surgical glove powder and intraperitoneal adhesion formation. An appeal for the use of powder-free surgical gloves. S Afr Med J 81:158-159, 1992
15. Jack D: Sticky situations: surgical adhesions and adhesives. Lancet 351:118, 1998
16. Kehrl JH: G-protein-coupled receptor signaling, RGS proteins, and lymphocyte function. Crit Rev Immunol 24:409-424, 2004
17. Sternini C, Patierno S, Selmer IS, Kirchgessner A: The opioid system in the gastrointestinal tract. Neurogastroenterol Motil 16:3-16, 2004
18. diZerega GS: Biochemical events in peritoneal tissue repair. Eur J Surg Suppl 577:10-16, 1997
19. Yao V, McCauley R, Cooper D, Platell C, Hall JC: Peritoneal mesothelial cells produce cytokines in a murine model of peritonitis. Surg Infect 5:229-236, 2004
20. Gomez-Roman JJ, Cifrian Martinez JM, Fernandez Rozas S, Fernando Val-Bernal J: Hormone expression and opioid receptors in fetal and adult lung. Arch Bronconeumol 38:362-366, 2002
21. Furness JB, Johnson PJ, Pompolo S, Bornstein JC: Evidence that enteric motility reflexes can be initiated through entirely intrinsic mechanisms in the guinea-pig small intestine. Neurogastroenterol Motil 7:89-96, 1995
22. Szolcsanyi J: Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 38:377-384, 2004
23. Rogers DF, Barnes PJ: Opioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet 1:930-932, 1989
24. Riedel W, Neeck G: Nociception, pain, and antinociception: current concepts. Z Rheumatol 60:404-415, 2001
25. Holmdahl L, Falkenberg M, Ivarsson ML, Risberg B: Plasminogen activators and inhibitors in peritoneal tissue. APMIS 105:25-30, 1997
26. Habara T, Nakatsuka M, Konishi H, Asagiri K, Noguchi S, Kudo T: The biological effects of antiadhesion agents on activated RAW264.7 macrophages. J Biomed Mater Res 61:628-633, 2002
27. Inoh K, Muramatsu H, Ochiai K, Torii S, Muramatsu T: Midkine, a heparin-binding cytokine, plays key roles in intraperitoneal adhesions. Biochem Biophys Res Commun 317:108-113, 2004
28. Bae JS, Ahn SJ, Yim H, Jang KH, Jin HK: Prevention of intraperitoneal adhesions and abscesses by polysaccharides isolated from Phellinus spp in a rat peritonitis model. Ann Surg 204:534-540, 2005
29. Chuang TK, Killam KF Jr, Chuang LF, et al.: Mu opioid receptors gene expression in immune cells. Biochem Biophys Res Commun 216:922-930, 1995
30. Bhat RS, Bhaskaran M, Mongia A, Hitosugi N, Singhal PC: Morphine-induced macrophage apoptosis: oxidative stress and strategies for modulation. J Leukoc Biol 75:1131-1138, 2004
31. LeGrand EK, Rodgers KE, Girgis W, Campeau JD, Dizerega GS: Comparative efficacy of nonsteroidal anti-inflammatory drugs and anti-thromboxane agents in a rabbit adhesion prevention model. J Invest Surg 8:187-194, 1995
32. Sheu JR, Yeh GC, Fang CL, Lin CH, Hsiao G: Morphine-potentiated agonist-induced platelet aggregation through alpha2-adrenoceptors in human platelets. J Cardiovasc Pharmacol 40:743-750, 2002
33. Vallejo R, de Leon-Casasola O, Benyamin R: Opioid therapy and immunosuppression: a review. Am J Ther 11:354-365, 2004
34. Nagai T, Yamada K, Yoshimura M, et al.: The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci USA 101:3650-3655, 2004